<DOC>
	<DOCNO>NCT02293889</DOCNO>
	<brief_summary>Knee Osteoarthritis ( KOA ) major cause pain disability , particularly increase age body fat . As effective therapy KOA , disease often progress knee replacement surgery need . It observe Vitamin D Physical Activity ( PA ) level low KOA , increase age body fat . As relationship KOA , Vitamin D PA level clearly understood , study aim explore relationship acceptability/feasibility PA Vitamin D intervention would likely benefit intervention . 200-300 people , 50-70 year , BMI 30-40kg/m2 , meet American College Rheumatology ( ACR ) KOA Guidelines , recruit North Tyneside Liverpool Hospital trust November 2014-January 2016 participate single cross-sectional study visit , measure : Vitamin D/Calcium serum level , BMI/Body Fat , mobility , Quality life pain ( questionnaire ) , PA level . Those participant insufficient Vitamin D level ( 25-50nmol/L ) PA level ( &lt; 30min moderate PA/week ) , invite take part 3 month pilot RCT study . &gt; 64 people recruit pilot RCT equally randomly allocate 1 4 intervention group : Vitamin D ( 1 capsule day : 2000IU ) , Placebo ( identical capsule : 1 day ) , PA ( online PA programme ) PA Vitamin D. Additionally end 12 week study visit , 20 participant invite take part qualitative interview explore experience two study .</brief_summary>
	<brief_title>Impact Physical Activity Vitamin D Osteoarthritic Knee Pain</brief_title>
	<detailed_description>The primary aim project test feasibility acceptability increase PA Vitamin D supplementation intervention old , obese people knee osteoarthritis , low baseline level PA Vitamin D perform 2*2 design pilot randomize control trial qualitative interview . The secondary aim project : 1 . Explore relationship Vitamin D level , PA level KOA pain ( use cross-sectional study result ) 2 . Estimate effect size inter-individual variation use design future definitive RCT . The project refer 2 integrated study : - Firstly cross-sectional study identify individual low vitamin D concentration , low Physical activity level , obese meet ACR KOA criterion knee osteoarthritis . - Secondly pilot randomize controlled trial , aim test feasibility acceptability administer vitamin D placebo capsule increase physical activity 3 month period . These 2 study run consecutively 2 winter period phase : phase 1 ( November 2014- January 2015 : cross sectional study follow intervention study ( February 2015- May 2015 ) . Phase 2 run time period 1 year later . 1 . Cross-sectional study potential participant identification ( November 2014-January 2015 ) : On Tyneside , investigator identify potential participant screen GP surgery patient list inclusion criterion ( see A17-1 ) . At Liverpool site , participant identify research staff hospital clinic ( obesity ) . Potentially eligible people mailed/given letter invitation , together information study consent form take home consider . Those interested joining study invite contact local research team use contact information provide . 2 . Cross-sectional study screening ( November-January 2014/15 ) : Potential participant complete brief telephone screen questionnaire call register interest study verify eligibility . The CI call back inform potential participant eligibility , eligible , appointment make attend cross-sectional study visit ( study visit 1 ) . 3 . Cross-sectional study visit : study visit 1 ( November-January 2014/15 ) : Participants attend appointment North Tyneside General Hospital Aintree Hospital Liverpool ( depend research site ) last 1 hour 30 minute . The visit begin review participant information sheet complete consent form . After , several measurement complete : - Blood sample - Questionnaires - Body composition At end study visit , participant give accelerometer wear next 3 day . Participants provide instruction accelerometer use , activity log prepay envelope return device . 4 . Screening eligibility pilot RCT ( January 2015 ) : Using data cross-sectional study , participant low vitamin D concentration ( 25-50nmol/L ) low physical activity level ( &lt; 30min/week moderate activity ) invite participate pilot RCT . 5 . Pilot RCT starter session ( study visit 2 ) ( February 2015/16 ) : Participants attend starter session pilot RCT study North Tyneside General Hospital Aintree hospital Liverpool . Prior appointment , participant randomly allocate ( stratified gender ) 1 4 treatment arm : - Vitamin D supplementation : 2000IU/day vitamin D capsule - Placebo : 1/day edible oil capsule ( identical vitamin D capsule ) - Physical activity intervention ( online system record daily step use pedometer provide , slowly increase step physical activity goal ) - Vitamin D + Physical activity intervention . The investigator explain undertake intervention , provide study material answer question participant may . Vitamin D Placebo intervention blind participant . 6 . 6 week follow ( study visit 3 ) ( March 2015/16 : All pilot RCT participant invite back 6 week intervention period study visit last 1-1hr 15 minute , either NTGH UHA . The measurement take cross-sectional study visit take additional compliance measure . 7 . 12 week follow ( study visit 4 ) ( April/May 2015/16 ) : All pilot RCT participant invite back 12 week intervention period study visit last 1-1hr 15 minute NTGH UHA . This study close take part qualitative interview . The measurement take study visit 3 . Participants mail feedback study measure include vitamin D status . 8 . Qualitative interview ( April/May 2015/16 ) : A subset 20 participant invite take part qualitative interview NTGH UHA directly study visit 4 . The interview last 1hr explore participant view range topic may identify area improvement design , delivery practical arrangement study order inform future study area .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>CROSS SECTIONAL STUDY 1 . Obese : BMI 3040kg/m2 define WHO criteria 2 . Older adult : 50 70 year 3 . OA knee accord ACR Guidelines symptomatic Knee OA criterion ( use history physical examination : • Pain knee AND 3 OF THE FOLLOWING : Over 50 year age Less 30 minute morning stiffness Crepitus active motion Bony tenderness Bony enlargement No palpable warmth synovial 4 . Good understanding write spoken English ( translation service available study ) . PILOT STUDY All inclusion criterion crosssectional study ( ) , plus : 1 . Low objectively measure level Vitamin D , define : Insufficient ( 2550nmol/L ) , exclude deficient ( &lt; 25 nmol/L ) , 25OHD concentration symptom result Vitamin D deficiency commonly occur . 2 . Low PA record accelerometer define : &lt; 30min/week moderate PA , &lt; 15min/week vigorous PA ( 2*credit moderate activity ) define 'inactive ' UK government guideline . Activities count occur &gt; 10mins bout . Activity define moderate make participant 'breathe faster , feel warm sweat ' increased heart rate . Activities identify moderate include : brisk walking , cycling , gardening , housework , DIY , climb stair carry heavy load . CROSSSECTIONAL STUDY 1 . Any type arthritic condition , e.g . RA , Fibromyalgia , Ankylosing Spondylitis , Gout , Lupus , Paget 's Disease , Polymyalgia rheumatic ( PMR ) , Psoriatic arthritis , Scleroderma , Sjogrens Syndrome 2 . Currently take part PA/exercise regime 3 . Taking Vitamin D , cod liver oil Calcium capsules/supplements ( topical/oral/intravenous , prescribed/nonprescribed ) 10µg/day vitamin D and/or 500µg/day calcium . 4 . Taking part another intervention/trial ( depend researcher discretion ) 5 . Chronic alcohol abuse ( &gt; 21 ( woman ) 28 ( men ) SI units/week PILOT STUDY The exclusion criterion crosssectional study , plus : 1 . Conditions interfere Vitamin D supplement adsorption : Malabsorption syndrome : e.g . cystic fibrosis , celiac disease , whipples disease , Crohns Disease , Bypass Surgery , short bowel syndrome , Diagnosed restrictive eating disorder Hypercalcaemia ( albuminadjusted plasma calcium &gt; 2.60 mmol/l ) Hypocalcaemia ( albuminadjusted plasma calcium &lt; 2.15 mmol/l ) Renal Stage 45 Chronic Kidney Disease : GFR &lt; 30 ml/min/1.73m2 Primary hyperparathyroidism 2 . Conditions affect normal baseline level vitamin D : Current pregnancy , delivery child/breast feeding 1 year prior recruitment Holiday significant sunlight exposure ( specified list sunny destination ) last 3 month plan holiday sunny/skiing destination duration study . Current Anticonvulsant drug therapy Current Glucocorticoid use Current HIV/treatment Antiretroviral drug Current antioestrogen ( aromatase inhibitor , oestrogen receptor inhibitor selective oestrogen receptor moderator ) use treat breast cancer Those currently take cytostatic/antitumour drug Granulomatous disorder : sarcoidosis , TB , Lymphomas 3 . Current condition may make worse/prompts complication vitamin D consumption Chronic Renal Disease : stage 4 5 ( see ) Liver disease Histoplasmosis hyperparathyroidism Hypocalcaemia hypercalcemia ( define ) Lymphoma Current/recent ( last 6 month ) supplementation ( topical/oral/intravenous , prescribed nonprescribed ) : Phosphorous , &gt; 10µg/day Vitamin D &gt; 500mg/day Calcium</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Knee osteoarthritis</keyword>
	<keyword>Pain</keyword>
	<keyword>Vitamin D</keyword>
	<keyword>Physical activity</keyword>
	<keyword>Pilot study</keyword>
	<keyword>Qualitative Interview</keyword>
	<keyword>Obesity</keyword>
	<keyword>Older adult</keyword>
</DOC>